Conclusions-ISH can be performed successfully with formic acid decalcified bone marrow trephine biopsy specimens and long term cultures. The presence of M-CSF mRNA in myelomonocytic cells suggests that an autocrine mechanism contributes to monocyte differentiation. The absence of detectable M-CSF mRNA in biopsy stroma and its presence in stromal fibroblasts within bone marrow cultures probably reflects reduced sensitivity of ISH following tissue fixation and pro- The physiological basis of this spatial organisation is not known. Evidence from studies of cultured bone marrow indicate that growth factors needed for haemopoietic differentiation become bound to heparan sulphate proteoglycan in the extracellular matrix after secretion by stromal cells.23 Multipotential haemopoietic cells are able to interact with growth factors such as granulocyte-monocyte colony stimulating factor (GM-CSF) in this bound form and differentiate accordingly. Stromal localisation of growth factors within the extracellular matrix may create microenvironmental niches in which presentation of a particular combination of growth factors directs haemopoietic differentiation along specific pathways in a spatially restricted manner.4
Demonstration of the distribution of haemopoietic growth factors in stromal layers of long term bone marrow cultures or trephine biopsy specimens would provide powerful evidence for the existence of such microenvironmental niches. Immunohistochemical staining to investigate growth factor distribution within bone marrow has several limitations. Such an approach does not permit discrimination between sites of synthesis, stromal binding and uptake by responding cells. In long term culture systems diffusion of secreted growth factors may occur, which may not be relevant to the situation in vivo. Finally, currently available antibodies directed against haemopoietic growth factors have been developed primarily for enzyme linked immunosorbent assays or bioassays and most are poor reagents for immunohistochemistry.
In situ hybridisation has been used successfully in a variety of tissues to demonstrate sites of production ofmessenger RNA (mRNA) encoding proteins. Messenger RNA can be stained in routinely fixed and processed tissues as well as fresh cells and frozen tissue. Trephine biopsy specimens of bone marrow differ from many histological samples in that they require decalcification before being processed for embedding in wax. This is usually achieved by exposure to acid or to a chelating agent such as EDTA. Few studies have addressed the question of mRNA preservation in decalcified tissue samples and only one published report exists which describes mRNA in situ hybridisation in bone marrow trephine biopsy specimens.5 In Figure 1 (A) Demonstration using a 25 mer oligo dT probe. In most biopsy specimens no reactivity was seen with the M-CSF sense probe ( fig 2B) . 141 ** Eosinophils and their precursors were problematical in a few cases, giving non-specific reactions with sense and antisense M-CSF probes. This could be overcome by using dextran in place of polyethylene glycol in the hybridisation buffer, but only at the expense of a reduction in strength of the specific signal. As eosinophil precursors are readily recognised ' j morphologically in trephine biopsy specimens, it was not difficult to exclude them from ana-4 lysis in the few samples where non-specific reactivity occurred. Of the other cytokine probes tested, TNFa and IL-4 showed reactivity with haemopoietic cells. Tumour necrosis factor mRNA was present in a minor population of large, seemingly primitive cells * dispersed throughout the marrow spaces. Interleukin-4 mRNA was present in most promyelocytes and myelocytes comprising the paratrabecular zones ofearly granulopoiesis ( fig  3) . For both TNFot and IL-4, control sense * 4 oligonucleotide sequences gave no reaction. Compared with morphologically normal biopsy specimens, increased numbers of M-CSF mRNA producing cells were present in most *m specimens from patients with myelodysplastic syndromes, particularly in cases of chronic -CSF antisense myelomonocytic leukaemia and refractory blasts but much ibroblastic layer. anaemia with excess blasts (with or without I-CSF sense transformation) (fig 4) . Previous iming is present. munophenotypic studies have shown that biopsy specimens from such patients contain lar proportions increased numbers of monocytes, most marked nces.
in chronic myelomonocytic leukaemia.8 Biopsy specimens representing refractory anaemia with ringed sideroblasts, in which monocyte numbers are generally normal, did not show strable by hy-increased numbers of M-CSF mRNA pro-)e in all biopsy ducing cells. Examples of acute myeloid leuk-[though the in-aemia of FAB subtypes AML-M2 and AMLbetween speci-M5 were also studied. Blast cells in both catas no reactivity egories of disease were weakly positive, with e (fig 1 B) . In a no evidence of stronger reactivity or a higher r hybridisation proportion of reactive cells in cells ofthe AML-.ed by reducing M5 subtype.
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In situ hybridisation with mRNA using oligo )ridisation. The dT and M-CSF probes was also successfully bridisation was performed in long term bone marrow cultures enzymatic di-( fig 5) . M-CSF mRNA was demonstrated in pecimens, pos-developing monocytes and in small round ition, are highly macrophages adherent to the stromal layer, but not in elongated, highly spread macrophages known from immunophenotypic studies to be present in the stroma (Wilkins BS, unpublished observations). A weak M-CSF mRNA signal was also detected in spindle shaped and polygonal fibroblastic cells which predominate in bone marrow culture stroma. No reactivity was seen with the small, primitive cells in haemopoietic colonies.
Discussion
This study has shown that mRNA is preserved in bone marrow trephine biopsy specimens despite fixation and decalcification. Previously, mRNA in situ hybridisation has only been reported with trephine specimens decalcified using calcium chelating agents.5 That report related to K and X immunoglobulin light chain mRNA in plasma cells of multiple myeloma, expressed in high copy number within the neoplastic cells. Our study has shown that mRNA for M-CSF, a cytokine growth factor likely to be expressed in low copy number per cell,9 can also be detected using a non-isotopic in situ hybridisation technique. M-CSF is required for the differentiation of monocytes within bone marrow and for various aspects of macrophage maturation and activation.'0 The presence of M-CSF in cells of promonocyte/promyelocyte morphology in the trephine biopsy specimens, and in monocytes and macrophages in the bone marrow cultures suggests that an autocrine loop of M-CSF production and response may operate during monocyte differentiation. The apparent lack of precise correlation between cell types expressing M-CSF mRNA in biopsy specimens and cultures is partly caused by the difficulty of categorising relatively undifferentiated cells in haemopoietic colonies in bone marrow cultures. The lack of M-CSF signal in stromal fibroblasts in most of our trephine biopsy specimens was probably because of reduced sensitivity of the technique and/or reduced mRNA preservation in fixed, decalcified tissue compared with the bone marrow cultures.
It has been proposed that stromal microenvironments exist for haemopoiesis in culture,4 permitting or directing differentiation along restricted pathways. No preferential localisation of M-CSF mRNA production was seen in areas of stroma showing colony formation compared with areas not forming colonies. This is in keeping with the results of previous immunohistochemical studies ofmonocytopoiesis in bone marrow trephine biopsy specimens which showed that monocyte production, unlike granulocyte production, occurs in a dispersed fashion throughout the intertrabecular spaces.' We are currently studying the distribution of GM-CSF and G-CSF mRNA within cells in bone marrow trephine biopsy specimens and long term cultures to discover whether or not production of these growth factors is spatially restricted. 
